ClinConnect ClinConnect Logo
Search / Trial NCT01173406

Education Programme on Continuous Positive Airway Pressure Treatment

Launched by THE UNIVERSITY OF HONG KONG · Jul 30, 2010

Trial Information

Current as of June 03, 2025

Completed

Keywords

Continuous Positive Airway Pressure Treatment Adherence Education

ClinConnect Summary

Obstructive sleep apnoea (OSA) is a common sleep disorders associated with excessive daytime sleepiness and cardiovascular disease. It is prevalent both in populations of western and eastern countries. Continuous positive airway pressure (CPAP) therapy is an effective standard treatment and is widely prescribed for patients with OSA. However, the use of CPAP for such patients is disappointingly low. Low patient CPAP adherence limits the effectiveness of treatment. To determine whether there is a need for an extended education programme for the OSA patient in order to improve CPAP usage.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Aged 18 years or over.
  • 2. Newly diagnosed of OSA and will be starting CPAP therapy
  • Exclusion Criteria:
  • 1. Not suitable for CPAP therapy
  • 2. Previously received CPAP therapy
  • 3. Possesses restrictive and obstructive pulmonary diseases
  • 4. Possesses hypoventilation
  • 5. Under unstable health conditions
  • 6. pregnant
  • 7. History of psychiatric illness

About The University Of Hong Kong

The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.

Locations

Hong Kong Island, , Hong Kong

Patients applied

0 patients applied

Trial Officials

Agnes YK Lai, MSc

Principal Investigator

The University of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials